← Back to headlines
Eli Lilly Stock Rises on Positive Foundayo Trial Results
Eli Lilly's stock extended its rally following positive results from the ACHIEVE-3 trial, which boosted the outlook for its drug Foundayo.
8 Jun, 19:23 — 8 Jun, 19:23
Sources
Showing 1 of 1 sources
